| Income Statement |
| Total Revenue | 31.95M |
|
| Revenues (USD) | 31.95M |
| Cost of Revenue | 47.81M |
| Gross Profit | -15.86M |
| Operating Expenses | 4.99M |
| Research and Development Expense | 840.00K |
| Selling, General and Administrative Expense | 1.40M |
| Operating Income | -20.84M |
| Interest Expense | 29.00K |
| Income Tax Expense | 8.00K |
| Net Income | -20.58M |
| Net Income Common Stock | -20.58M |
| Net Income Common Stock (USD) | -20.58M |
| Consolidated Income | -20.58M |
| Earnings per Basic Share | -0.47 |
| Earnings per Basic Share (USD) | -0.47 |
| Earnings per Diluted Share | -0.47 |
| Dividends per Basic Common Share | 0.06 |
| Earning Before Interest & Taxes (EBIT) | -20.54M |
| Earning Before Interest & Taxes (USD) | -20.54M |
| Weighted Average Shares | 44.03M |
| Weighted Average Shares Diluted | 44.03M |
| Balance Sheet |
| Cash and Equivalents | 22.37M |
| Cash and Equivalents (USD) | 22.37M |
| Trade and Non-Trade Receivables | 13.31M |
| Current Assets | 84.14M |
| Property, Plant & Equipment Net | 89.88M |
| Total Assets | 179.00M |
| Current Liabilities | 17.57M |
| Total Liabilities | 37.07M |
| Accumulated Retained Earnings (Deficit) | -61.72M |
| Shareholders Equity | 141.93M |
| Shareholders Equity (USD) | 141.93M |
| Assets Non-Current | 94.85M |
| Deferred Revenue | 12.82M |
| Inventory | 31.10M |
| Liabilities Non-Current | 19.51M |
| Trade and Non-Trade Payables | 11.86M |
| Tax Assets | 82.00K |
| Tax Liabilities | 1.06M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.56M |
| Net Cash Flow from Financing | -2.63M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -28.95M |
| Capital Expenditure | -5.39M |
| Payment of Dividends & Other Cash Distributions | -2.63M |
| Net Cash Flow from Investing | -6.32M |
| Net Cash Flow - Investment Acquisitions and Disposals | -934.00K |
| Net Cash Flow from Operations | -20.00M |
| Share Based Compensation | 305.00K |